Lawsuit Overview
August 26, 2022 - An investor in shares of Humanigen, Inc. (NASDAQ: HGEN) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Humanigen, Inc. in connection with certain allegedly false and misleading statements made between May 28, 2021 and July 12, 2022. Burlingame, CA based Humanigen, Inc., a clinical stage ...
You must register (for free) or login to view the entire case.